Skip to main content

Table 1 Clinical and demographic findings of the studied groups

From: Changes in serum levels of apelin and nitric oxide in hospitalized patients with COVID-19: association with hypertension, diabetes, obesity, and severity of disease

 

CTL

HTN

DM

OB

COV

COV + HTN

COV + DM

COV + OB

Number

20

20

17

15

20

17

15

17

Male (%)

10 (50)

8 (40)

9 (52.9)

9 (60)

10 (50)

9 (52.9)

6 (40)

11 (64.7)

Age (years)

54 (20)

61 (18)a

50 (26.7)

43 (25)

63 (17.2)

67 (23)a

59 (14)

43 (14.7)

BMI (Kg/m2)

21.6 (2.7)

22.4 (2.43)

22 (4.2)

30.5 (2.1)c

22.4 (3.8)

24.3 (4.3)b

26 (4.4)b

31.15 (4.1)c

SBP (mmHg)

120 (20)

150 (23)c

114 (10)

110 (10)

130 (28)a

147 (35)c

130 (42)bd

130 (21)ae

DBP (mmHg)

70 (20)

90 (23)c

70 (10)

75 (10)

77 (18)

82 (22)b

79 (13.7)b

80 (16.5)b

DM history

No

No

Yes

No

No

No

Yes

No

HL history

No

No

No

No

No

No

2 (13.3℅)

No

HTN history

No

Yes

No

No

No

Yes

No

No

  1. The data are in n (%) or as median (IQR) the categorical variables were analyzed using the chi-square test. The continuous data were analyzed by Kruskal–Wallis test followed by Mann–Whitney U test
  2. CTL control (healthy people), COV COVID-19, HTN: hypertension, HL hyperlipidemia DM diabetes mellitus, OB: obesity, SBP: systolic blood pressure, DBP: diastolic blood pressure
  3. aP < 0.05
  4. bP < 0.01
  5. cP < 0.001 vs. CTL group
  6. dP < 0.05 vs. DM group
  7. eP < 0.05 vs. OB group